News & Insights
Find up-to-date information and news regarding important policy and industry updates affecting the long-term care pharmacy community. This page is updated regularly to include new research and federal policy impacts on this community.
Press Releases & Statements
As the only national organization exclusively representing the interests of LTC pharmacies, hear directly from SCPC.
Releases & Statements
09/19/2023
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
Read MoreReleases & Statements
08/29/2023
SCPC Calls for Solutions that Protect Long-term Care Patients and Pharmacies as White House Announces Initial List for Medicare Drug Price Negotiations
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the Biden administration’s announcement of the first 10 drugs selected for Medicare price negotiations, eight of which are heavily utilized by patients served by long-term care pharmacies.
Read MoreReleases & Statements
08/21/2023
2023 SCPC Summit Recap
In late July, the Senior Care Pharmacy Coalition (SCPC) gathered in Washington, D.C. for our annual Business Partners Summit where we discussed key issues and policies impacting the long-term care (LTC) pharmacy community and the unique role our members play in America’s healthcare system.
Read MoreIn The News
Recent coverage of SCPC in the news.
In the News
09/01/2023
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
Read MoreIn the News
08/30/2023
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
Read MoreIn the News
08/30/2023
Long-Term Care Pharmacies Say Negotiation Hurts Them Without PBM Reform
Long-term care pharmacies say the kick-off of Medicare drug price negotiation Tuesday (Aug. 29), while well-intentioned, will inadvertently hurt them and their patients unless policy makers also move forward on pharmacy benefit manager and Part D payment reforms. “Long term care pharmacies are likely to be collateral damage,” Alan Rosenbloom, president and CEO of the Senior Care Pharmacy Coalition, told Inside Health Policy.
Read MoreOur Videos
SCPC welcomes the opportunity to highlight the work of the LTC pharmacy community. To learn more about the LTC pharmacy sector, click the link below and watch the videos highlighting the important, unique work our members do in their communities.
Policy & Sector Insights
The LTC pharmacy sector is in constant change with new research, policies and news.
Policy & Sector Insights
10/17/2022
The surprising group that will be hit hard by drug pricing reform
By Rachel CohrsSTAT Obviously, pharmaceutical companies are upset that they’re going to lose money from Medicare under Democrats’ new drug pricing law. But there’s another, less obvious group that’s concerned as well — long-term care pharmacies that serve almost entirely Medicare patients, and dispense the drugs that will likely enter the price negotiation program first. […]
Read MorePolicy & Sector Insights
10/14/2022
Military Veterans Deserve Uninterrupted Pharmacy Access
Military Retirees Will Lose Long-Term Care Pharmacy Services as soon as Oct. 24, 2022 TRICARE and its Pharmacy Benefit: The TRICARE program, operated by the Department of Defense (Defense Health Agency), covers 9.6 million active-duty service members and their family members, along with military retirees, many of whom live in long-term care (LTC) facilities like […]
Read MorePolicy & Sector Insights
01/07/2022
Prescription Drug Policy, 2021 And 2022: The Year In Review, And The Year Ahead
By Rachel Sachs Health Affairs This past year was filled with news in the prescription drug policy area, from the Food and Drug Administration’s (FDA) most controversial drug approval in many years to ongoing discussions in Congress over drug pricing reform. Through it all, the importance of responding to the COVID-19 pandemic has remained at […]
Read More